Stevia
Stevia rebaudiana
Stevia (Stevia rebaudiana), a natural sweetener, is recognized in Ayurveda for its supposed ability to balance Vata, Pitta, and Kapha doshas. Traditionally, its leaves are claimed to offer a sweet alternative without calories, making it a prevalent choice for those seeking to manage sugar intake. This plant is widely used globally as a natural sweetener.
PLANT FAMILY
Asteraceae (Daisy)
AYURVEDIC ACTION
Kapha ↓, Pitta ↓, Vata ↓
ACTIVE COMPOUNDS
Steviol glycosides (4-20%)
What is Stevia?
Stevia, scientifically known as Stevia rebaudiana, is a species of plant native to Paraguay and Brazil, belonging to the Asteraceae (Daisy) family. It is widely cultivated for its leaves, which are a source of natural sweeteners known as steviol glycosides. These compounds are significantly sweeter than sugar but contribute no calories, making Stevia a popular alternative in various food and beverage products.
Historically, indigenous populations in South America have used Stevia for centuries as a natural sweetener and for medicinal purposes. Today, its global recognition has surged due to increasing demand for low-calorie and natural sweetening options, impacting industries from soft drinks to dietary supplements.
Other Names of Stevia
- Sweetleaf
- Sugarleaf
- Candyleaf
- Honey Yerba

Heading
<h3> Absolute Contraindications of Stevia </h3> <h4>Pregnancy and Early Development (avoid high-dose/excess use)</h4> <ul> <li>🤰 <li>Recommendation: Avoid high-dose stevia extracts during pregnancy and do not use medicinal/large supplemental doses; discuss any regular use with your obstetrician. <li>Reasoning: Some animal developmental studies report fetal/maternal toxicity at very high steviol doses in pregnant animals; human safety data in pregnancy are limited so caution is advised. <li>Scientific_Study_Title: Developmental toxicity of steviol, a metabolite of stevioside, in the hamster. <li>Scientific_Study_Authors: Toyoda K, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/9598301/ <li>Scientific_Study_Excerpt: <p>In this experimental study, pregnant hamsters dosed with high amounts of steviol (0.75-1.0 g/kg BW/day) during organogenesis showed marked maternal and fetal toxicity, including reduced maternal weight gain, increased maternal mortality, and reduced numbers and weights of live fetuses. At the intermediate dose (0.5 g/kg/day) toxicity was less but still present. The authors concluded that at very high doses steviol produced developmental toxicity in hamsters; these doses are far higher than typical dietary exposures in humans.</p> </ul> <h4>Prepubertal / Developing Males - Chronic high-dose exposure (avoid medicinal use)</h4> <ul> <li>🚫 <li>Recommendation: Avoid chronic high-dose stevia extracts in prepubertal boys or animals; do not use medicinal doses without pediatric specialist advice. <li>Reasoning: Animal studies report reduced reproductive organ weights, lowered sperm concentrations and potential reductions in testosterone after prolonged, high-dose stevia extracts - suggesting possible effects on male reproductive development in rodents. <li>Scientific_Study_Title: Effects of chronic administration of Stevia rebaudiana on fertility in rats. <li>Scientific_Study_Authors: Cainelli CE, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10619379/ <li>Scientific_Study_Excerpt: <p>In prepubertal male rats given prolonged aqueous Stevia extract, investigators observed decreased final weights of testes, seminal vesicles and epididymal structures, lower fructose content in accessory glands, and reduced epididymal sperm concentration. Plasma testosterone tended to be lower; luteinizing hormone levels were unchanged. The authors suggested chronic high-dose exposure affected male reproductive organs and sperm parameters in this rat model.</p> </ul> <h4>Basal Low Blood Pressure / Uncontrolled Hypotension</h4> <ul> <li>⚠️ <li>Recommendation: Do not use stevia medicinally if you already have chronically low blood pressure or symptomatic hypotension without physician approval. <li>Reasoning: Multiple human trials demonstrate that stevioside can lower blood pressure in hypertensive patients; therefore in people with low baseline blood pressure or taking multiple antihypertensives, further lowering may be unsafe. <li>Scientific_Study_Title: A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. <li>Scientific_Study_Authors: Hsieh MH, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10971305/ <li>Scientific_Study_Excerpt: <p>This randomized, double-blind trial in hypertensive patients found that oral stevioside (250 mg TID) significantly reduced systolic and diastolic blood pressure over months; effects persisted throughout the year. No major adverse events were reported in that hypertensive population. Because the compound reproducibly lowers blood pressure in patients with hypertension, the study supports caution or avoidance in people with low baseline pressures or on multiple blood-pressure medications.</p> </ul> <h3> Relative Contraindications of Stevia </h3> <h4>Concurrent use with sulfonylurea antidiabetic drugs (e.g., glimepiride)</h4> <ul> <li>💊 <li>Recommendation: Use with caution; consult your prescribing clinician and monitor blood glucose closely if combining stevia supplements with sulfonylureas or insulin-secreting drugs. <li>Reasoning: Metabolites of steviol are handled by renal transporters (OAT3). Certain antidiabetic drugs (and other drugs) can inhibit OAT3 and alter steviol metabolite levels; this can modify exposure and theoretically influence blood-glucose effects. <li>Scientific_Study_Title: Interaction of Organic Anion Transporter 3-Mediated Uptake of Steviol Acyl Glucuronide, a Major Metabolite of Rebaudioside A, with Selected Drugs. <li>Scientific_Study_Authors: Chen M-L, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31760750/ <li>Scientific_Study_Excerpt: <p>Laboratory and in vivo data showed SVAG (a chief metabolite) is an OAT3 substrate. Probenecid and glimepiride potently inhibited OAT3-mediated SVAG transport (IC50 4.9 and 0.8 μM, respectively). Co-administration elevated plasma SVAG Cmax and AUC after rebaudioside A dosing, indicating drugs that inhibit OAT3 can increase circulating steviol metabolites and alter pharmacokinetics.</p> </ul> <h4>Concomitant use with drugs relying heavily on UGT2B7 (e.g., diclofenac as a model UGT2B7 substrate)</h4> <ul> <li>⚗️ <li>Recommendation: If you take medications metabolized primarily by UGT2B7, discuss stevia supplements with your clinician; they may recommend monitoring or dose adjustments. <li>Reasoning: Steviol is glucuronidated mainly by UGT2B7. Drugs that strongly inhibit or compete at UGT2B7 may alter steviol clearance or vice versa. <li>Scientific_Study_Title: Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates. <li>Scientific_Study_Authors: Liang Y, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24296138/ <li>Scientific_Study_Excerpt: <p>In human liver microsomes and recombinant UGT systems, steviol glucuronidation was primarily mediated by UGT2B7 (at low concentrations) and by UGT2B7 plus UGT1A3 at higher concentrations. Inhibition studies showed diclofenac inhibited steviol glucuronidation (Ki ≈ 4.2 μM), implying potential for mutual alteration of clearance when co-administered with potent UGT2B7 substrates or inhibitors.</p> </ul> <h4>History of GI sensitivity / functional gut disorders (IBS, frequent GI upset)</h4> <ul> <li>🤢 <li>Recommendation: If you experience recurrent bloating, diarrhea, or abdominal pain with sweeteners, test a small amount or avoid stevia extracts; consult a gastroenterologist if severe. <li>Reasoning: Clinical trials and reviews report gastrointestinal adverse events (abdominal fullness, epigastric pain, diarrhea) in some people consuming steviol glycosides. <li>Scientific_Study_Title: Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. <li>Scientific_Study_Authors: Gardana C, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25412840/ <li>Scientific_Study_Excerpt: <p>The systematic review and meta-analysis noted adverse events reported across trials, including abdominal fullness, epigastric pain and dizziness. Heterogeneity between trials was substantial, but GI complaints were among the most commonly reported tolerability issues linked to steviol glycoside consumption in randomized trials.</p> </ul>
Heading
<h4>Stomach upset: bloating, abdominal fullness, diarrhea</h4> <ul> <li>🤢 <li>Side effect summary: Some people experience bloating, a feeling of fullness, abdominal discomfort or loose stools after consuming stevia products. <li>Recommendation: Reduce dose or stop use; try a product with pure high-purity rebaudioside A (fewer additives) and discuss persistent symptoms with a clinician. <li>Reasoning: Randomized trials and meta-analyses list GI complaints among the most common adverse events reported with steviol glycoside consumption. <li>Severity Level: Mild <li>Scientific_Study_Available: Yes <li>Scientific_Study_Title: Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. <li>Scientific_Study_Authors: Gardana C, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25412840/ <li>Scientific_Study_Excerpt: <p>The meta-analysis reported that trials frequently recorded tolerability events such as abdominal fullness and epigastric pain among participants consuming steviol glycosides. While many events were mild and transient, the authors highlighted heterogeneity across studies and recommended further safety assessment, particularly for GI tolerability in sensitive populations.</p> </ul> <h4>Possible additive blood-pressure lowering (lightheadedness, dizziness)</h4> <ul> <li>🩺 <li>Side effect summary: Some users report lightheadedness or dizziness; stevia can lower blood pressure, especially in hypertensive individuals-this may feel like dizziness in susceptible people. <li>Recommendation: If you are on antihypertensives or feel faint after using stevia, stop and consult your prescriber; monitor blood pressure. <li>Reasoning: Placebo-controlled trials show stevia lowers systolic/diastolic pressure in hypertensive subjects; additive effects can occur with other BP-lowering therapies. <li>Severity Level: Moderate <li>Scientific_Study_Available: Yes <li>Scientific_Study_Title: A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. <li>Scientific_Study_Authors: Hsieh MH, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10971305/ <li>Scientific_Study_Excerpt: <p>The trial observed clinically significant decreases in both systolic and diastolic blood pressure among hypertensive participants treated with stevioside over months. The paper notes good tolerability overall but supports the physiological potential for blood-pressure lowering, which can manifest as dizziness if combined with other hypotensive factors.</p> </ul> <h4>Theoretical genotoxicity signals in lab tests (limited clinical relevance)</h4> <ul> <li>⚗️ <li>Side effect summary: Some in vitro tests flagged mutagenic signals at high concentrations in certain bacterial assays; however, in vivo and long-term animal studies generally do not show carcinogenic risk at realistic doses. <li>Recommendation: No change for typical dietary use; avoid very large medicinal doses pending medical advice. <li>Reasoning: Early in vitro mutagenicity assays showed limited positive findings at high concentrations, but broader in vivo tests and regulatory reviews conclude low risk at dietary exposures. <li>Severity Level: Mild <li>Scientific_Study_Available: Yes <li>Scientific_Study_Title: Mutagenicity and human chromosomal effect of stevioside, a sweetener from Stevia rebaudiana Bertoni. <li>Scientific_Study_Authors: Brambilla G, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8143647/ <li>Scientific_Study_Excerpt: <p>In bacterial (Ames) tests, stevioside was non-mutagenic at lower concentrations but showed activity in one strain at very high test concentrations; steviol was not mutagenic. Cultured human lymphocyte tests showed no chromosomal effects. Authors recommended further in vivo genotoxic testing; regulatory reviews later considered dietary exposures safe.</p> </ul>
Heading
<h4>Sulfonylureas (e.g., glimepiride)</h4> <ul> <li>Interaction_Details: Laboratory and pharmacokinetic data show that glimepiride inhibits OAT3, a kidney uptake transporter important for clearing steviol metabolites; co-use increased plasma levels of steviol metabolites in animal/drug-interaction models and could modify glycemic effects. <li>Severity: Moderate <li>Recommendation: Consult your prescriber; monitor blood glucose closely and consider dose review of antidiabetic drugs if you add regular stevia supplements. <li>Scientific_Study_Available: Yes <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31760750/ <li>Scientific_Study_Title: Interaction of Organic Anion Transporter 3-Mediated Uptake of Steviol Acyl Glucuronide, a Major Metabolite of Rebaudioside A, with Selected Drugs. <li>Scientfic_Study_Authors: Chen M-L, Ito K, et al. <li>Scientific_Study_Excerpt: <p>The study demonstrated that SVAG (steviol acyl glucuronide) is a substrate of OAT3. Probenecid and glimepiride potently inhibited OAT3-mediated SVAG transport (IC50 values 4.9 and 0.8 μM). In vivo co-administration with probenecid or glimepiride significantly increased plasma SVAG Cmax and AUC after rebaudioside A dosing, indicating that inhibition of renal OAT3 can elevate circulating steviol metabolite exposure.</p> </ul> <h4>Drugs metabolized or interacting with UGT2B7 (e.g., diclofenac as a model)</h4> <ul> <li>Interaction_Details: Steviol is cleared by glucuronidation (UGT2B7). Drugs that inhibit or compete at UGT2B7 may alter steviol clearance; conversely, steviol may compete for glucuronidation pathways in high doses. <li>Severity: Mild <li>Recommendation: If taking strong UGT2B7 inhibitors or high-risk UGT substrates, mention stevia use to your clinician; monitoring may be advised. <li>Scientific_Study_Available: Yes <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24296138/ <li>Scientific_Study_Title: Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates. <li>Scientfic_Study_Authors: Liang Y, Chun J, et al. <li>Scientific_Study_Excerpt: <p>Investigators found steviol glucuronidation is primarily mediated by UGT2B7 in human liver microsomes and recombinant systems. Diclofenac was shown to inhibit steviol glucuronidation (Ki ~4.2 μM), indicating the potential for mutual influence on clearance when co-administered with potent UGT2B7 inhibitors or substrates.</p> </ul> <h4>Antihypertensive agents (general class)</h4> <ul> <li>Interaction_Details: Stevioside has demonstrable blood-pressure lowering effects in hypertensive patients; combining with other blood-pressure medications could produce additive hypotension. <li>Severity: Moderate <li>Recommendation: Monitor blood pressure closely and discuss with your clinician before starting regular stevia supplements if you take antihypertensives. <li>Scientific_Study_Available: Yes <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/10971305/ <li>Scientific_Study_Title: A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. <li>Scientfic_Study_Authors: Hsieh MH, et al. <li>Scientific_Study_Excerpt: <p>Randomized trial data indicate oral stevioside reduced both systolic and diastolic blood pressure in hypertensive participants compared with placebo. Because of this reproducible hypotensive effect, clinicians should anticipate possible additive lowering when stevia is combined with prescription antihypertensives and counsel patients accordingly.</p> </ul> <h4>Drugs metabolized via CYP pathways (general statement)</h4> <ul> <li>Interaction_Details: In vitro work indicates steviol glycosides induce only minor or no clinically relevant changes in major CYP enzyme activities; large or clinically meaningful CYP-mediated drug interactions appear unlikely based on current in vitro evidence. <li>Severity: Mild <li>Recommendation: No routine CYP-related adjustments needed for most drugs, but always inform your clinician of supplements you use. <li>Scientific_Study_Available: Yes <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/29655729/ <li>Scientific_Study_Title: In vitro effects of rebaudioside A, stevioside and steviol on porcine cytochrome p450 expression and activity. <li>Scientfic_Study_Authors: Poulsen L, et al. <li>Scientific_Study_Excerpt: <p>Using primary hepatocytes and microsomes, the study found rebaudioside A, stevioside and steviol caused only minor changes in CYP expression or activity, with no direct strong inhibition of specific CYP activities. Authors concluded significant food-drug interactions via CYP pathways are unlikely, although in vivo human data remain limited.</p> </ul>